Skip to content
Screener

Bio-Rad Laboratories BIO Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$213M+6.5%
MaxCyte logo
MaxCyteMXCT
$0
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$0
Personalis, Inc. logo
Personalis, Inc.PSNL
$1.1M

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.16B+28.0%
Enterprise value$9.63B+17.5%
P/E54.2×+31.8×
P/S3.5×+0.7×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Line itemMarch 31, 2026December 31, 2025
Finance Leases
Property, plant and equipment, gross$11.5$11.5
Less: accumulated depreciation and amortization(6.4)(6.4)
Property, plant and equipment, net$5.1$5.1
Current maturities of long-term debt and notes payable$0.5$0.5
Long-term debt, net of current maturities8.68.7
Total finance lease liabilities$9.1$9.2

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's finance lease liabilities (total)?
Bio-Rad Laboratories (BIO) reported finance lease liabilities (total) of $9.1M in Q1 2026.
How has Bio-Rad Laboratories's finance lease liabilities (total) changed year-over-year?
Bio-Rad Laboratories's finance lease liabilities (total) decreased by 4.2% year-over-year, from $9.5M to $9.1M.
What is the long-term trend for Bio-Rad Laboratories's finance lease liabilities (total)?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's finance lease liabilities (total) has grown at a -4.4% compound annual growth rate (CAGR), from $11.5M to $9.2M.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.

Ask your AI about Bio-Rad Laboratories's finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude